Squamous cell carcinoma of the oral cavity

Advocacy intelligence hub — real-time data for patient organizations

View full disease page →Search clinical trials →
Download CSV

At a Glance

Live from database

Regulatory Watchboard

10 events
Apr 2026Safety and Feasibility of Nivolumab-IRDye800CW in Patients With Head and Neck Squamous Cell Carcinoma (HNSCC)

Vanderbilt-Ingram Cancer Center — PHASE1

TrialNOT YET RECRUITING
Apr 2026A Study Evaluating the Contribution of Non-Coplanar Beam Arrangement in Reducing Toxicity in Radiotherapy for Upper Aerodigestive Tract Cancers

Centre Georges Francois Leclerc — NA

TrialNOT YET RECRUITING
Apr 2026Impact of Postoperative Radiotherapy Versus PD-1 Inhibitor Maintenance on Survival in Resectable Locally Advanced Oral and Oropharyngeal Squamous Cell Carcinoma

Zhujiang Hospital

TrialNOT YET RECRUITING
Jan 2026Sintilimab Plus Chemotherapy as Neoadjuvant and Adjuvant Treatment for Locally Advanced Oral Squamous Cell Carcinoma

Qunxing Li,MD — PHASE3

TrialRECRUITING
Nov 2025A Study to Assess the Adverse Events, Change in Disease Activity, and How Oral ABBV-711 Tablets Move Through the Body as a Monotherapy and in Combination With Intravenously Infused Budigalimab (ABBV-181), in Adults With Advanced Squamous Tumors

AbbVie — PHASE1

TrialRECRUITING
Aug 2025Adebrelimab Combined With Carboplatin and Albumin-bound Taxanol in the Treatment of Resectable Locally Advanced Oral Squamous Cell Carcinoma Cardiac, Randomized, Phase II Exploratory Study

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University — PHASE2

TrialNOT YET RECRUITING
Jul 2025Prospective Cohort Study on Oral Microbiome Changes in Patients With Locally Advanced Oral Squamous Cell Carcinoma Following Neoadjuvant Chemoimmunotherapy

Zhujiang Hospital

TrialRECRUITING
Jul 2025Neoadjuvant and Adjuvant Sintilimab Plus Cetuximab in Locally Advanced Oral and Oropharyngeal Squamous Cell Carcinoma

Shanghai Zhongshan Hospital — PHASE2

TrialNOT YET RECRUITING
May 2025Heterogeneity of Oral Squamous Cell Carcinoma Analysis by Single Cell RNA Sequencing

Centre Leon Berard — NA

TrialNOT YET RECRUITING
May 2025Intratumoral Delivery of Viral Replicon (saRNA) Particles Expressing IL-12 in Head and Neck Cancer

VLP Therapeutics — PHASE1

TrialRECRUITING

Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Financial Assistance

FINANCIAL LANDSCAPE SUMMARY

0

Total programs

No financial assistance programs currently listed for Squamous cell carcinoma of the oral cavity.
Check the disease page for updates →

Approved Treatments

1 FDA-approved

LYMPHOSEEK

(technetium Tc 99m tilmanocept)Orphan drugstandard

Cardinal Health 414, LLC

12.1 Mechanism of Action Lymphoseek (technetium Tc 99m tilmanocept) is a radioactive diagnostic agent. It accumulates in lymphatic tissue and selectiv...

FDA label ↗

View full treatment details on disease page →

Clinical Trial Landscape

14 active trials
2Phase 3
4Phase 2
2Phase 1
3N/A
1Unknown
1PHASE2, PHASE3
1PHASE1, PHASE2
14Total recruiting
Search clinical trials for Squamous cell carcinoma of the oral cavity

Recent News & Research

No recent news articles indexed yet for Squamous cell carcinoma of the oral cavity.
Search PubMed for Squamous cell carcinoma of the oral cavity

Browse all Squamous cell carcinoma of the oral cavity news →

Specialist Network

Top 6 by expertise

View all Squamous cell carcinoma of the oral cavity specialists →

Quick Actions